Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
January 2023
in “
Annual Review of Cancer Biology
”
TLDR Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.
The document discusses how somatic mutations in normal tissues contribute to early carcinogenesis, emphasizing that cancer risk is more related to the balance of pro- and anti-oncogenic mutations rather than the total mutation burden. It highlights the role of environmental factors, such as metabolic changes, inflammation, and radiation, in influencing mutant clone dynamics. The study suggests that understanding the competitive advantage of mutant clones and identifying mutations that drive clonal expansion could lead to interventions to prevent oncogenic mutant expansion, potentially reducing cancer risk. The research underscores the complexity of mutant clonal dynamics and the need for further study, particularly in human tissues, to better understand these processes and their implications for cancer risk.